Discover a powerful cleaning duo for your home. Vinegar and hydrogen peroxide, when used one after another, offer an effective and eco-frie...

"A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome which would tailor the correct antib...

This is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...

"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial s...

The problem starts because some people do not wash their hands properly.

Copper can destroy MRSA and MSSA 'superbugs' spread by touching and fingertip contamination of surfaces, a new study has claimed.

Humans carry more antibiotic-resistant bacteria than the farm animals they handle, a new study on dairy farmers has found.

Date syrup is able to inhibit the growth of bacteria and is increasingly used in dressings to improve wound repair.

The stock soared 13.23 per cent to settle at Rs 184.45 on the BSE. During the day, it climbed 18.41 per cent to Rs 192.90.

Long after we have swiped and tapped our smartphones, sent or received personal texts, our devices retain a biological history of our actio...

Drug firm Venus Remedies received additional patent approval from USPTO for its product 'Vancoplus', used for treating bacterial infections.

The patent has been granted by Mexico Patent office and is valid till February 2026, Venus said in a release.

Venus Remedies Limited, a leading research based global pharmaceutical company has secured its first patent from Canada for its novel antib...

Drug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.

Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, has received final approval from the USFDA for Mupirocin ointment.

Drug maker Wockhardt said on Friday it will spin off its R&D business and list the new company on stock exchange on January 1, 2009.

Wockhardt is likely to out-license some of its research molecules to global pharma companies.